The Ews-ERG fusion protein can initiate neoplasia from lineage-committed haematopoietic cells

PLoS Biology

Volumn 3, Issue 8, 2005, Pages

  Codrington, Rosalind ^a   Pannell, Richard ^a   Forster, Alan ^a   Drynan, Lesley F ^a   Daser, Angelika ^a   Lobato, Nati ^a   Metzler, Markus ^a   Rabbitts, Terence H ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CRE RECOMBINASE; ERG PROTEIN; RAG1 PROTEIN; RNA BINDING PROTEIN EWS; UNCLASSIFIED DRUG; EWS ERG FUSION PROTEIN, HUMAN; EWS-ERG FUSION PROTEIN, HUMAN; INTEGRASE; MESSENGER RNA; ONCOPROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL LINEAGE; CONTROLLED STUDY; DNA FLANKING REGION; GENE CASSETTE; GENE EXPRESSION; GENE FUSION; INTRON; LEUKEMIA; LOXP SITE; LYMPHOID CELL; MESENCHYME CELL; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE; PROTEIN FUNCTION; T LYMPHOCYTE; ANIMAL; B LYMPHOCYTE; BONE MARROW; CYTOLOGY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE RECEPTOR GENE; THYMOMA;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; BONE MARROW; CELL LINEAGE; GENES, T-CELL RECEPTOR BETA; HUMANS; INTEGRASES; LEUKEMIA, T-CELL; LYMPHOMA, T-CELL; MICE; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; ONCOGENE FUSION; ONCOGENE PROTEINS, FUSION; RNA, MESSENGER; T-LYMPHOCYTES; THYMOMA; THYMUS NEOPLASMS; TRANSCRIPTION FACTORS; VIRAL PROTEINS;

EID: 23944458598     PISSN: 15449173     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pbio.0030242     Document Type: Article

References (49)

1. Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372: 143-149.
2. Look AT (1997) Oncogenic transcription factors in the human acute leukemias. Science 278: 1059-1065.
3. Mitelman F, Johansson B, Mertens F, editors (2000) Mitelman Database of Chromosome Aberrations in Cancer [database]. Bethesda (Maryland): National Cancer Institute. Available: http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed 19 May 2005.
4. Huntly BJ, Gilliland DG (2005) Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer 5: 311-321.
5. Gale RP, Grosveld G, Canaani E, Goldman JM (1993) Chronic myelogenous leukemia: Biology and therapy. Leukemia 7: 653-658.
6. Jaiswal S, Traver D, Miyamoto T, Akashi K, Lagasse E, et al. (2003) Expression of BCR-ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proc Natl Acad Sci U S A 100: 10002-10007.
7. Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, et al. (2004) MOZ-TIF2, but not BCR-ABL, confers properties of leukaemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6: 587-596.
8. Jamieson CH, Weissman IL, Passegue E (2004) Chronic versus acute myelogenous leukemia: A question of self-renewal. Cancer Cell 6: 531-533.
9. Ayton PM, Cleary ML (2001) Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene Revs 20: 5695-5707.
10. Daser A, Rabbitts TH (2004) Extending the repertoire of the mixed lineage leukemia gene MLL in leukemogenesis. Genes and Develop 18: 965-974.
11. Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, et al. (2003) Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 17: 3029-3035.
12. Arvand A, Denny CT (2001) Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20: 5747-5754.
13. Bennicelli JL, Barr FG (2002) Chromosomal translocations and sarcomas. Curr Opin Oncol 14: 412-419.
14. Sandberg AA, Bridge JA (2003) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: Chondrosarcoma and other cartilaginous neoplasms. Cancer Genet Cytogenet 143: 1-31.
15. Sandberg AA (2004) Genetics of chondrosarcoma and related tumors. Curr Opin Oncol 16: 342-354.
16. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, et al. (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359: 162-165.
17. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, et al. (1993) EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4: 341-345.
18. Sorensen PHB, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, et al. (1994) A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6: 146-151.
19. Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, et al. (1995) A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10: 1229-1234.
20. Urano F, Umezawa A, Hong W, Kikuchi H, Hata J (1996) A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun 219: 608-612.
21. Peter M, Couturier J, Pacquement H, Michon J, Thomas G, et al. (1997) A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14: 1159-1164.
22. Kim J, Lee K, Pelletier J (1998) The desmoplastic small round cell tumor t(11;22) translocation produces EWS/Wt1 isoforms with differing oncogenic properties. Oncogene 16: 1973-1979.
23. Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, et al. (1996) Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene 12: 229-235.
24. Crozat A, Aman P, Mandahl N, Ron D (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363: 640-644.
25. Rabbitts TH, Forster A, Larson R, Nathan P (1993) Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4: 175-180.
26. Shimizu K, Ichikawa H, Tojo A, Kaneko Y, Maseki N, et al. (1993) An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. Proc Natl Acad Sci U S A 90: 10280-10284.
27. Ichikawa H, Shimizu K, Hayashi Y, Ohki M (1994) An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54: 2865-2868.
28. Panagopoulos I, Aman P, Fioretos T, Hoglund M, Johannson B, et al. (1994) Fusion of the FUS gene in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosomes Cancer 11: 256-262.
29. Panagopoulos I, Hoglund M, Mertens F, Mandhal N, Mitelman F, et al. (1996) Fusion of the EWS and CHOP gene in myxoid liposarcoma. Oncogene 12: 489-494.
30. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, et al. (1996) An Mll-Af9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes. Cell 85: 853-861.
31. Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, et al. (1999) The Mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J 18: 3564-3574.
32. Buchholz F, Refaeli Y, Trumpp A, Bishop JM (2000) Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. EMBO Rep 1: 133-139.
33. Collins EC, Pannell R, Simpson EM, Forster A, Rabbitts TH (2000) Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. EMBO Rep 1: 127-132.
34. Forster A, Pannell R, Drynan LF, McCormack M, Collins EC, et al. (2003) Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. Cancer Cell 3: 449-458.
35. Forster A, Pannell R, Drynan LF, Codrington R, Daser A, et al. (2005) The invertor knock-in conditional chromosomal translocation mimic. Nat Methods 2: 27-30.
36. McCormack MP, Forster A, Drynan LF, Pannell R, Rabbitts TH (2003) The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Mol Cell Biol 23: 9003-9013.
37. Morse HC 3rd, Anver MR, Fredrickson TN, Haines DC, Harris AW, et al. (2002) Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100: 246-258.
38. Miyamoto T, Iwasaki H, Reizis B, Ye M, Graf T, et al. (2002) Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev Cell 3: 137-147.
39. Soriano P (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21: 70-71.
40. Malissen M, Minard K, Mjolsness S, Kronenberg M, Goverman J, et al. (1984) Mouse T cell antigen receptor: Structure and organization of constant and joining gene segments encoding the β polypeptide. Cell 37: 1101-1110.
41. Neuberger MS, Caskey HM, Pettersson S, Williams GT, Surani MA (1989) Isotype exclusion and transgene down-regulation in immunoglobulin-λ transgenic mice. Nature 338: 350-352.
42. Aifantis I, Buer J, von Boehmer H, Azogui O (1997) Essential role of the pre-T cell receptor in allelic exclusion of the T cell receptor beta locus. Immunity 7: 601-607.
43. Gartner F, Alt FW, Monroe R, Chu M, Sleckman BP, et al. (1999) Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion. Immunity 10: 537-546.
44. Lefranc MP (2002) IMGT, the international ImMunoGeneTics database: A high-quality information system for comparative immunogenetics and immunology. Dev Comp Immunol 26: 697-705.
45. Lefranc MP, Pommie C, Ruiz M, Giudicelli V, Foulquier E, et al. (2003) IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 27: 55-77.
46. Prasad DDK, Ouchida M, Lee L, Rao VN, Reddy ES (1994) TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 9: 3717-3729.
47. Warren AJ, Colledge WH, Carlton MBL, Evans MJ, Smith AJH, et al. (1994) The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78: 45-58.
48. Feinberg AP, Vogelstein BA (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13.
49. LeFranc MP, Forster A, Baer R, Stinson MA, Rabbitts TH (1986) Diversity and rearrangement of the human T cell rearranging γ genes: Nine germline variable genes belonging to two subgroups. Cell 45: 237-246.